Compounds > disulfiram

disulfiram and bryostatin 1

disulfiram has been researched along with bryostatin 1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullen, CK; Durand, CM; Laird, GM; Siliciano, JD; Siliciano, RF1
Bullen, CK; Durand, CM; Hill, AL; Laird, GM; Martin, AR; Rosenbloom, DI; Siliciano, JD; Siliciano, RF1

Other Studies

2 other study(ies) available for disulfiram and bryostatin 1

ArticleYear
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.
    Nature medicine, 2014, Volume: 20, Issue:4

    Topics: Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Depsipeptides; Disulfiram; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Indoles; Ionomycin; Lymphocyte Activation; Nuclear Proteins; Panobinostat; Tetradecanoylphorbol Acetate; Transcription Factors; Triazoles; Virus Latency; Vorinostat

2014
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:5

    Topics: Adult; Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cells, Cultured; Disulfiram; Drug Evaluation, Preclinical; Drug Synergism; Female; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Lymphokines; Male; Middle Aged; Phorbol Esters; Protein Kinase C; RNA, Messenger; RNA, Viral; Transcription, Genetic; Triazoles; Virion; Virus Latency

2015